000			02239cam a2200349 a 4500
003			EG-GiCUC
005			20250223031346.0
008			151202s2015 ua dh f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aPh.D
099			_aCai01.11.22.Ph.D.2015.Sh.L
100	0		_aShaimaa Ahmed Abdelmonem Elrasad
245	1	0	_aLow versus high dose radioactive Iodine- 131 ablation of remnant thyroid tissue after surgical treatment of differentiated thyroid carcinoma / _cShaimaa Ahmed Abdelmonem Elrasad ; Supervised Shrief Mohammed Elrefaei , Maha Abdelkareem Hosseini , Rehab Ahmed Abdelmeguid
246	1	5	_aمقارنة بين الجرعات الكبيرة والجرعات الصغيرة من اليود المشع لعلاج بقايا نسيج الغدة الدرقية بعد العلاج الجراحي لسرطان الغدة الدرقية المميز
260			_aCairo : _bShaimaa Ahmed Abdelmonem Elrasad , _c2015
300			_a152 Leaves : _bcharts , facsimiles ; _c25cm
502			_aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Nuclear Medicine
520			_aThis study is now redirected to Avoid the unneeded use of high doses of RAI-131 in post-operative ablation of residual thyroid tissue in cases of differentiated thyroid cancer with no gross residual disease or distal metastasis and to increase patient convenience, through administering low dose of 131I to the postoperative patients indicated for ablation guided by pathology report, operative data, and trustable neck U.S. This study suggests that the low dose RAI-131 is as effective as the high doses in post- operative ablation of the residual thyroid tissue in patients of differentiated cancer with no gross residual disease or distal metastasis
530			_aIssued also as CD
653		4	_aAGES
653		4	_aCarcinoma
653		4	_aRAI-131
700	0		_aMaha Abdelkareem Hosseini , _eSupervisor
700	0		_aRehab Ahmed Abdelmeguid , _eSupervisor
700	0		_aShrief Mohammed Elrefaei , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aSoheir _eCataloger
942			_2ddc _cTH
999			_c53695 _d53695